Ospemifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C24H23ClO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B0P231ILBK, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol but more generally known as ospemifene, which bears US NIH Compound Identifier 3036505. European Medicines Agency schedules Ospemifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB33020. The term OSPEMIFENE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). Most nations, for tariff and trade purposes, schedule ospemifene under HS 29094990 and SITC 51617. As of Q4 2014, OSPEMIFENE remains US FDA's Preferred Term for this commodity. Ospemifene bears US NLM identifiers UMLS ID C1313616 and NCI Concept Code C76958. SMILES: CLCC/C(=C(/C1CCC(OCCO)CC1)C1CCCCC1)C1CCCCC1.